The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

The FDA announced that Maquet Datascope Corp. has recalled a hybrid intra-aortic balloon pump due to a design issue that allows fluid, such as saline, to seep into the device. The agency designated ...

Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe arrhythmias or heart rates up to 200 beats per minute, including those who were originally ...

MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...

This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, ...

A Japanese study of intra-aortic balloon pumps appears to indicate the devices do little to improve outcomes for patients with acute cases and may increase the chances of death. In the registry study ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...

According to a recent report by Consegic Business Intelligence, the intra aortic balloon pumps market is poised for strong expansion and is expected to reach USD 528.25 Million by 2030. The market, ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...